Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
暂无分享,去创建一个
I. Derweesh | R. Campi | E. Roussel | M. Marchioni | L. Hampton | V. Hevia | S. Erdem | M. Meagher | N. Paksoy | F. Claps | G. Rebez | E. Linares | M. D’anna | Alessandro Antonelli | Riccardo Autorino | N. Pavan | M. Albersen | C. Cerrato | Andrea Minervini | M. C. Mir | Maximilian Kriegmair | Maria Musquera